JNJ - JOHNSON & JOHNSON
165.86
-1.840 -1.109%
Share volume: 9,879,194
Last Updated: 03-11-2025
Pharmaceutical Products/Pharmaceutical Preparations:
0.03%
PREVIOUS CLOSE
CHG
CHG%
$167.70
-1.84
-0.01%
View ratios
| Fiscal Date | 12-31-2023 | 12-31-2023 | 03-31-2024 | 03-31-2024 | 06-30-2024 | 06-30-2024 | 09-29-2024 | 12-29-2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q4 2023 | Q4 2023 | Q1 2024 | Q1 2024 | Q2 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 02-13-2025 | 02-16-2024 | 05-01-2024 | 05-01-2024 | 07-25-2024 | 07-25-2024 | 10-23-2024 | 02-13-2025 | |
| Assets | |||||||||
| Total Assets | 167.558 B | 167.558 B | 171.966 B | 171.966 B | 181.088 B | 181.088 B | 178.287 B | 180.104 B | |
| Current Assets | 53.495 B | 53.495 B | 57.002 B | 57.002 B | 57.817 B | 57.817 B | 53.249 B | 55.893 B | |
| Inventories | 11.181 B | 11.181 B | 11.383 B | 11.383 B | 12.169 B | 12.169 B | 12.603 B | 12.444 B | |
| Other Current Assets | 0.000 | 4.514 B | 0.000 | 4.455 B | 0.000 | 4.379 B | 0.000 | 0.000 | |
| Short Term Investments | 1.068 B | 4.514 B | 745.000 M | 4.455 B | 597.000 M | 4.379 B | 317.000 M | 417.000 M | |
| Total Receivables | 0.000 | 14.873 B | 0.000 | 14.946 B | 0.000 | 15.794 B | 0.000 | 0.000 | |
| Current Cash | 21.859 B | 22.927 B | 25.473 B | 26.218 B | 24.878 B | 25.475 B | 19.980 B | 24.105 B | |
| Total Non-current Assets | 0.000 | 114.063 B | 0.000 | 114.964 B | 0.000 | 123.271 B | 0.000 | 0.000 | |
| Property Plant Equipment | 19.898 B | 19.898 B | 19.632 B | 19.632 B | 19.748 B | 19.748 B | 20.479 B | 20.518 B | |
| Other Assets | 94.165 B | 9.680 B | 95.332 B | 14.125 B | 103.523 B | 10.544 B | 104.559 B | 103.693 B | |
| Intangible Assets | 0.000 | 34.175 B | 0.000 | 34.286 B | 0.000 | 39.725 B | 0.000 | 0.000 | |
| Goodwill | 0.000 | 36.558 B | 0.000 | 36.616 B | 0.000 | 44.250 B | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 167.558 B | 167.558 B | 171.966 B | 171.966 B | 181.088 B | 181.088 B | 178.287 B | 180.104 B | |
| Total liabilities | 98.784 B | 98.784 B | 101.946 B | 101.946 B | 109.550 B | 109.550 B | 108.129 B | 108.614 B | |
| Total current liabilities | 46.282 B | 46.282 B | 48.725 B | 48.725 B | 53.933 B | 53.933 B | 51.759 B | 50.321 B | |
| Accounts Payable | 9.632 B | 9.632 B | 8.174 B | 8.174 B | 8.848 B | 8.848 B | 8.954 B | 10.311 B | |
| Other liabilities | 13.398 B | 23.428 B | 15.067 B | 24.967 B | 14.086 B | 21.346 B | 14.923 B | 17.549 B | |
| Current long term debt | 0.000 | 3.451 B | 0.000 | 8.550 B | 0.000 | 9.855 B | 0.000 | 0.000 | |
| Long term debt | 25.881 B | 25.881 B | 25.082 B | 25.082 B | 31.636 B | 31.636 B | 31.289 B | 30.651 B | |
| Other liabilities | 13.398 B | 23.428 B | 15.067 B | 24.967 B | 14.086 B | 21.346 B | 14.923 B | 17.549 B | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 68.774 B | 68.774 B | 70.020 B | 70.020 B | 71.538 B | 71.538 B | 70.158 B | 71.490 B | |
| Common stock | 3.120 B | 2.407 B | 3.120 B | 2.408 B | 3.120 B | 2.407 B | 3.120 B | 3.120 B | |
| Retained earnings | 153.843 B | 153.843 B | 153.378 B | 153.378 B | 155.360 B | 155.360 B | 155.179 B | 155.791 B |